The Diabetes Pearl: diabetes biobanking in the Netherlands

Completed

• Conditions: Type 2 diabetes; Nutritional, Metabolic, Endocrine; Type 2 diabetes mellitus

• Registration Number: ISRCTN37454880
• Lead Sponsor: VU Universtity Medical Center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2017-01-06
• Last Update Posted: 6 February 2017

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 7000

Inclusion Criteria

1. Patients with type 2 diabetes mellitus according to WHO criteria
2. Treated by a Dutch University Clinic, an associated primary care clinic or transmural care system

Exclusion Criteria

None

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Diabetes complications and mortality:<br>1. Cardio-metabolic risk factors, assessed by anthropometry, blood pressure, ECG, ankle-brachial index, laboratory measurements, and self-report questionnaire at baseline<br>2. Retinopathy, assessed by retinal photography at baseline<br>3. Nephropathy, assessed with laboratory measurements at baseline<br>4. Neuropathy, assessed by peripheral vibration perception at baseline<br>Follow-up visits have not been planned yet. Follow-up of morbidity and mortality is done through medical care providers and municipal registries.

Secondary Outcome Measures

Name	Time	Method
Quality of life and physical functioning, assessed by self-reported questionnaire at baseline